Autopsy report · NCT04746976

Study of Diroximel Fumarate in the Real-World Setting

“Sponsor's Decision”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 2 years 1 month before it stopped.
• 75 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Biogen

Sponsor type

Industry

Conditions

Relapsing Forms of MS

Interventions

Diroximel Fumarate

Participants

75

Sites

18

Countries

United States

Trials that died the same way

• Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors
  “Sponsor decision” (98% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.